# Open-Label, Randomized Study Evaluating the Absorption and Systemic Pharmacokinetics of Topically Applied IDP-126 Gel in Comparison With Control Gel

> **NCT03653403** · PHASE1 · COMPLETED · sponsor: **Bausch Health Americas, Inc.** · enrollment: 61 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** IDP-126 Gel
- **DRUG:** Control Gel

## Key facts

- **NCT ID:** NCT03653403
- **Lead sponsor:** Bausch Health Americas, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-08
- **Primary completion:** 2019-06-19
- **Final completion:** 2019-06-19
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2019-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03653403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03653403, "Open-Label, Randomized Study Evaluating the Absorption and Systemic Pharmacokinetics of Topically Applied IDP-126 Gel in Comparison With Control Gel". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03653403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*